Skip to main content
logo
Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
8.94
+0.33 (3.83%)
At close: Oct 14, 2026, 4:00 PM EDT
9.02
+0.08 (0.89%)
Pre-market: Oct 15, 2026, 8:25 AM EDT

Electra Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
66.5133.0114.79
Short-Term Investments
31.2253.511
Cash & Short-Term Investments
97.7386.5215.79
Cash Growth
-448.10%-
Other Receivables
0.260.220.06
Receivables
0.260.220.06
Prepaid Expenses
1.988.573.42
Other Current Assets
0.390.180.17
Total Current Assets
100.3695.4919.42
Property, Plant & Equipment
2.412.78-
Other Long-Term Assets
1.831.1-
Total Assets
106.599.3719.42

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
4.614.081.54
Accrued Expenses
8.195.052.66
Current Portion of Leases
0.830.61-
Total Current Liabilities
13.639.734.2
Long-Term Leases
1.161.48-
Total Liabilities
14.7811.214.2

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Additional Paid-In Capital
2.459.527.74
Retained Earnings
-221.89-172.98-111
Comprehensive Income & Other
-0.010.020
Total Common Equity
-219.46-163.44-103.26
Shareholders' Equity
91.7288.1615.23
Total Liabilities & Equity
106.599.3719.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
1.982.09-
Net Cash (Debt)
95.7484.4315.79
Net Cash Growth
-434.88%-
Net Cash Per Share
2175.951918.89358.75
Filing Date Shares Outstanding
61.10.040.04
Total Common Shares Outstanding
0.040.040.04
Working Capital
86.7485.7615.23
Book Value Per Share
-4987.61-3714.59-2346.84
Tangible Book Value
-219.46-163.44-103.26
Tangible Book Value Per Share
-4987.61-3714.59-2346.84
SEC Filings: 10-K · 10-Q